Viewing Study NCT00758004


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2026-03-01 @ 1:26 PM
Study NCT ID: NCT00758004
Status: COMPLETED
Last Update Posted: 2021-02-18
First Post: 2008-09-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study Of Pediatric Appropriate Formulation
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module